安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- EPKINLY® for 3L+ DLBCL and FL
EPKINLY® (epcoritamab-bysp) is a bispecific antibody given by subcutaneous injection for adults with diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) that returned or didn't respond after 2 or more prior treatments
- What is EPKINLY®? Treatment for 3L+ DLBCL and FL
Learn how EPKINLY® (epcoritamab-bysp) is used to treat 3L+ diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) See Important Safety Information, full Prescribing Information and Medication Guide, and Boxed Warnings
- Starting on EPKINLY® (epcoritamab-bysp)
EPKINLY® (epcoritamab-bysp) is an FDA-approved bispecific antibody given as a subcutaneous injection EPKINLY® uses a step-up dosing schedule and can be received at an outpatient center See Important Safety Information, full Prescribing Information and Medication Guide, and Boxed Warnings
- EPKINLY® for 3L+ Diffuse Large B-Cell Lymphoma (DLBCL)
EPKINLY® (epcoritamab-bysp) is a bispecific antibody given by subcutaneous injection for adults with certain types of diffuse large B-cell lymphoma (DLBCL) that returned or didn't respond after 2 or more prior treatments
- Clinical Trial Results - EPKINLY® (epcoritamab-bysp)
View EPKINLY® (epcoritamab-bysp) clinical trial results for diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) that returned or didn't respond after 2 or more prior treatments See Important Safety Information, full Prescribing Information and Medication Guide, and Boxed Warnings
- What to Expect with EPKINLY
To help reduce your risk of CRS, you will receive EPKINLY on a step-up dosing schedule (when you receive 2 or 3 smaller step-up doses of EPKINLY before your first full dose during your first cycle of treatment), and you may also receive other medicines before and for 3 days after receiving EPKINLY
- EPKINLY® for 3L+ Follicular Lymphoma (FL)
EPKINLY® (epcoritimab-bysp) is a bispecific antibody given by subcutaneous injection for adults with follicular lymphoma (FL) that returned or didn't respond after 2 or more prior treatments
- DLBCL and FL Support and Resources - EPKINLY® (epcoritamab-bysp)
EPKINLY is a prescription medicine used to treat adults with certain types of diffuse large B-cell lymphoma (DLBCL), high-grade B-cell lymphoma, or follicular lymphoma (FL) that has come back or that did not respond to previous treatment after receiving 2 or more treatments
|
|
|